Artiva Biotherapeutics (NASDAQ:ARTV) Rating Reiterated by Needham & Company LLC
Needham & Company LLC reaffirmed their buy rating on shares of Artiva Biotherapeutics (NASDAQ:ARTV – Free Report) in a report released on Friday morning, Benzinga reports. Needham & Company LLC currently has a $23.00 target price on the stock. A number of other brokerages have also issued reports on ARTV. Wedbush initiated coverage on shares […]
More Stories
The Hunter Biden Laptop Cover-Up: How Politicians and Spies Influenced a U.S. Election
By Stephen Zogopoulos, USNN World News In the months leading up to the 2020 U.S. Presidential election, the Hunter Biden...
Horizon Bancorp (NASDAQ:HBNC) Reaches New 52-Week High After Dividend Announcement
Horizon Bancorp, Inc. (NASDAQ:HBNC – Get Free Report)’s share price reached a new 52-week high during trading on Wednesday following...
Applied Optoelectronics, Inc. (NASDAQ:AAOI) Given Consensus Rating of “Moderate Buy” by Analysts
Applied Optoelectronics, Inc. (NASDAQ:AAOI – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the four...
Endava (NYSE:DAVA) Updates FY 2025 Earnings Guidance
Endava (NYSE:DAVA – Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company...
MillerKnoll (NASDAQ:MLKN) Updates FY 2025 Earnings Guidance
MillerKnoll (NASDAQ:MLKN – Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company...
UMB Financial Co. (NASDAQ:UMBF) Given Average Rating of “Buy” by Brokerages
Shares of UMB Financial Co. (NASDAQ:UMBF – Get Free Report) have earned an average rating of “Buy” from the six...